Brief: Scope Fluidics Unit Completes Fifth Stage Of R&D Works On PCR|ONE System
April 7 (Reuters) - Scope Fluidics SA SCPP.WA :
* UNIT CURIOSITY DIAGNOSTICS COMPLETES FIFTH STAGE OF
RESEARCH AND
DEVELOPMENT WORKS ON PCR|ONE SYSTEM
* RESULTS CONFIRM HIGH CLINICAL EFFECTIVENESS OF PCR|ONE
SYSTEM,
WITH MARKER PARAMETERS IN LINE WITH MARKET STANDARDS
* SAYS CO DECIDES TO EXPAND WORKS ON PANEL FOR DETECTING
VIRAL
RESPIRATORY INFECTION
* SAYS EXPANSION TO INCLUDE DEVELOPMENT OF ULTRAFAST GENETIC
SARS-COV-2 RECOGNITION TEST
Source text for Eikon: ID:nEM2S2L9Wa
Further company coverage: SCPP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Scope Fluidics SA
See all newsBrief: Scope Fluidics' EDOCERA Project Meets Second Goal Of Developing Prototype Of Device For Detecting Stroke Symptoms
Brief: Scope Fluidics Q2 Net Loss At 10.1 Million Zlotys
Brief: Scope Fluidics Unit Signs Deal With Poland's PARP For Up To 14.4 Mln Zlotys In Funding For HYBOLIC Project
Brief: Scope Fluidics Says FDA Certification For UNI FAST Panel Planned For Second Half Of 2027
Brief: Scope Fluidics Extends Deadline For First Goal In Hybolic Project